Business Context and Reporting Period
Company: Deckers Outdoor Corporation
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and six months ended June 30, 2001
Business Overview: The Company designs, markets, and distributes outdoor footwear and apparel under the Teva, Simple, and Ugg brands. Operations are highly seasonal, with Teva sales peaking in the first half of the year and Ugg sales peaking in the fourth quarter.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2001 | Six Months Ended June 30, 2001 |
|---|---|---|
| Net Sales | $21,586,000 | $56,497,000 |
| Gross Profit | $9,597,000 (44.5% margin) | $25,331,000 (44.8% margin) |
| Operating Earnings | $1,349,000 | $5,430,000 |
| Net Earnings | $731,000 | $3,218,000 |
| Diluted EPS | $0.08 | $0.34 |
| Cash and Equivalents | $22,032,000 (as of June 30, 2001) | |
| Working Capital | $42,471,000 (as of June 30, 2001) | |
| Debt | Total debt: $655,000 ($412k current, $243k long-term). No borrowings under $50M credit facility. | |
| Operating Cash Flow | $15,046,000 (Six months) |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 25.4% for the quarter and 20.3% for the six-month period compared to 2000. Drivers included a softening economy, colder weather in key markets, the sale of the Heirlooms subsidiary (Picante brand), and a significant reduction in sales to Track 'n Trail following its bankruptcy.
- Margin Compression: Gross margin decreased to 44.5% (Q3) and 44.8% (YTD) from 47.5% and 46.8% in the prior year periods, primarily due to an increased volume of closeout sales and a shift in sales mix toward lower-priced styles.
- Expense Management: Selling, general, and administrative (SG&A) expenses decreased in absolute dollars but increased as a percentage of sales (38.2% for Q3) due to fixed costs not declining proportionally with revenue.
- Segment Performance:
- Teva: Sales down 21.8% (Q3) and 17.5% (YTD); operating earnings declined significantly.
- Simple: Sales down 36.4% (Q3); operating loss widened to $274,000.
- Ugg: Sales down 31.6% (Q3); operating loss widened to $516,000.
- Liquidity Improvement: Cash and cash equivalents increased from $9.1M to $22.0M, driven by strong operating cash flow and reduced inventory levels.
Guidance, Outlook, and Risks
Management Guidance (Fiscal Year 2001)
- Net Sales: Expected to range from $95 million to $100 million.
- Diluted EPS: Expected to range from $0.40 to $0.45 (excluding potential Molly litigation impact).
- Q3 2001 Outlook: Sales expected between $15 million and $17 million; diluted loss per share expected between $0.09 and $0.10.
Key Risks and Contingencies
- Molly Litigation: A jury verdict of $1.785 million plus interest was affirmed by the court of appeals on August 8, 2001. The case was remanded for determination of exemplary damages and attorney fees. The Company has accrued $620,000 but the final financial impact remains uncertain.
- Customer Concentration: Bankruptcy of major customer Track 'n Trail resulted in significant bad debt write-offs and sales reductions.
- Weather Sensitivity: Sales are highly dependent on weather conditions; cooler spring/summer weather negatively impacted Teva sales.
- Teva Acquisition Option: The Company holds an option to acquire Teva assets. Exercising this option would require significant additional financing, which is not guaranteed. The first option window was extended to December 31, 2003.
- Operational Risks: Potential disruption from rolling electrical power outages in California where offices and distribution centers are located.
Investor Verification Checklist
- Legal Exposure: Verify the final outcome and total cost of the Molly Strong-Butts litigation, including potential exemplary damages and attorney fees.
- Customer Concentration: Assess the Company's ability to replace sales volume lost from the Track 'n Trail bankruptcy.
- Inventory Valuation: Monitor inventory levels and obsolescence reserves given the shift to closeout sales and lower average selling prices.
- Teva Option Strategy: Evaluate the Company's intent and financial capacity to exercise the Teva acquisition option, which requires substantial capital.
- Seasonality Shift: Confirm if the anticipated shift in seasonality (stronger Q4 due to Ugg) materializes as forecasted.